Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OBN Supports Stem Cell Patentability Consortium Letter

Published: Wednesday, July 17, 2013
Last Updated: Wednesday, July 17, 2013
Bookmark and Share
Letter calls for patentability of products derived from pluripotent stem cells.

Abingdon, UK - OBN, the membership organisation supporting and bringing together the UK's emerging life sciences companies, corporate partners and investors, announces its participation in the Stem Cell Patentability Consortium aimed at protecting the interests of life science companies working in the stem cell field.

Stem cell-based therapies hold much promise for the treatment of a variety of acquired and inherited diseases and for the formation of replacement organs.  The development of such products relies on the manipulation of human embryonic stem cells and its commercial viability is currently in the balance as the European Court of Justice considers the meaning of the term “human embryo” in the context of patenting  - covered by the Legal Protection of Biotechnological Inventions Directive 98/44/EC.

As the law stands a patent which includes the use of a “human embryo” for industrial or commercial purposes cannot be patented.  The Consortium, created and led by law firm Matthew Arnold & Baldwin LLP (MAB), has been formed to support and argue the view that the use of pluripotent stem cells derived from an unfertilised embryo through parthenogenesis should not be regarded as “human embryos” as they are not capable of development of a viable human being.  The Consortium argues that patentability of this technology is crucial to the commercial viability of the embryonic stem cell research, the public interest for the treatment of human illness and the competitive position of the EU.

The Consortium has drafted a letter to be sent to the UK IPO who is positioned to advise the UK Government on its response to the European Court of Justice over the issue.   The strength of this submission is increased by the number and quality of signatories and OBN is supporting this initiative with its contacts within the stem cell industry.  If you are interested in influencing the outcome of this debate please become a signatory.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
How Skeletal Stem Cells Form The Blueprint Of The Face
USC researchers discover that two types of molecular signals work to control where and when stem cells turn into facial cartilage.
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Stem Cells Know How to Unwind
Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long-term and unrestricted developmental potential in embryonic stem cells.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Skin Cells Turned into Heart Cells and Brain Cells Using Drugs
In a scientific first, Gladstone researchers have used chemical drugs to convert skin cells into heart cells and brain cells, without adding any external genes.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!